Selective neuronal nitric oxide synthase inhibitors

被引:53
作者
Erdal, EP
Litzinger, EA
Seo, JW
Zhu, YQ
Ji, HT
Silverman, RB [1 ]
机构
[1] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA
[2] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA
[3] Northwestern Univ, Ctr Drug Discovery & Chem Biol, Evanston, IL 60208 USA
关键词
D O I
10.2174/1568026054679317
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review includes the non-patent literature up to October 2004 that deals with selective neuronal nitric oxide synthase inhibitors (highest potency is for the neuronal isozyme). Some non-selective inhibitors or selective inducible nitric oxide synthase inhibitors are mentioned if they are related to compounds that are discussed; structures of these compounds generally are not given. In vitro inhibition constants are given either as IC50 values or as Ki values. An IC50 value, the inhibitor concentration that produces 50% inhibition in the presence of a constant concentration of substrate, is obtained by extrapolation of several rate data points to 50% inhibition. K-i values are derived from several types of plots that relate the concentration of inhibitor with enzyme velocity in the presence of a variety of substrate concentrations [1]. The K-i value can be estimated from the IC50 value [2]. Although the two inhibition constants are related, they are not the same; generally, the reported Ki values tend to be lower than the IC50 values. If specifics are desired about how the data were collected, then the reader will have to look in the literature cited. No attempt was made to be exhaustive in citing all references related to specific inhibitors; rather, examples of literature references are given for each inhibitor described.
引用
收藏
页码:603 / 624
页数:22
相关论文
共 213 条
[1]   Nitric oxide related therapeutic phenomenon:: A challenging task [J].
Alcaraz, MJ ;
Guillén, MI .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (03) :215-231
[2]   Novel neuronal nitric oxide synthase (nNOS) selective inhibitor, aplysinopsin-type indole alkaloid, from marine sponge Hyrtios erecta [J].
Aoki, S ;
Ye, Y ;
Higuchi, K ;
Takashima, A ;
Tanaka, Y ;
Kitagawa, I ;
Kobayashi, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (10) :1372-1374
[3]  
Ashina Messoud, 2002, Expert Opin Pharmacother, V3, P395, DOI 10.1517/14656566.3.4.395
[4]   Asymmetric synthesis of conformationally restricted L-arginine analogues as active site probes of nitric oxide synthase [J].
Atkinson, RN ;
Moore, L ;
Tobin, J ;
King, SB .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (10) :3467-3475
[5]   Novel inhibitors of neuronal nitric oxide synthase with potent antioxidant properties [J].
Auvin, S ;
Auguet, M ;
Navet, E ;
Harnett, JJ ;
Viossat, I ;
Schulz, J ;
Bigg, D ;
Chabrier, PE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (02) :209-212
[6]   Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries [J].
Ayajiki, K ;
Fujioka, H ;
Okamura, T ;
Toda, N .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 423 (2-3) :179-183
[7]   INHIBITION OF RAT CEREBELLAR NITRIC-OXIDE SYNTHASE BY 7-NITRO INDAZOLE AND RELATED SUBSTITUTED INDAZOLES [J].
BABBEDGE, RC ;
BLANDWARD, PA ;
HART, SL ;
MOORE, PK .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (01) :225-228
[8]  
Babu BR, 2000, PORTL PR P, V16, P145
[9]   N5-(1-imino-5-butenyl)-L-ornithine -: A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase [J].
Babu, BR ;
Griffith, OW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8882-8889
[10]   L-arginine binding to nitric-oxide synthase - The role of H-bonds to the nonreactive guanidinium nitrogens [J].
Babu, BR ;
Frey, C ;
Griffith, OW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25218-25226